Follow us on Twitter
twitter icon@FreshPatents

Clinical Trial patents

      

This page is updated frequently with new Clinical Trial-related patent applications.




 System and  preparation of clinical trial budgets patent thumbnailSystem and preparation of clinical trial budgets
Medical and other research organizations, sites within those organizations, and physicians practicing at those sites register in an online database. The company providing the database posts a description of a clinical trial opportunity or other research opportunity.

 Process for the preparation of n,n-dicyclopropyl-4-(1,5-dimethyl-1h-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide patent thumbnailProcess for the preparation of n,n-dicyclopropyl-4-(1,5-dimethyl-1h-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide
The invention relates to an improved process for synthesizing n,n-dicyclopropyl-4-(1,5-dimethyl-1h-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide of the formula: (i) compound (i) is currently in clinical trials for the treatment of myeloproliferative disorders, such as polycythaemia vera, thrombocythaemia and primary myelofibrosis.. .
Bristol-myers Squibb Company


 Method to decrease brain injury following cerebral ischemia patent thumbnailMethod to decrease brain injury following cerebral ischemia
A method to immediately treat cerebral ischemia caused by hemorrhage, thrombosis or spasm is described. The method requires an apparatus comprising a tight fitting non-rebreathing mask with one way expiratory valves and a pressure regulated source of compressed oxygen.

 Reverse vaccination therapy of multiple sclerosis patent thumbnailReverse vaccination therapy of multiple sclerosis
Disclosed are means of inducing antigen-specific tolerance through genetically modifying msc to express antigens of interest in an inducible manner or constitutive manner. Msc have been demonstrated to suppress pathological immunity in an antigen-nonspecific manner in vitro and in vivo, including clinical trials of gvhd, type 1 diabetes, and multiple sclerosis.
Creative Medical Health, Llc


 Therapy for subarachnoid hemorrhage and ischemia patent thumbnailTherapy for subarachnoid hemorrhage and ischemia
The application provides data from a clinical trial of a psd-95 inhibitor in subjects undergoing endovascular repair of an aneurysm in or otherwise affecting the cns. The subjects were stratified by whether the aneurysm ruptured before performing the endovascular surgery.
Nono Inc.


 Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines patent thumbnailSerum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines
Disclosed herein are diagnostic assays for identifying individuals that are protected against plasmodium falciparum caused malaria. Such assays are particularly useful for determining not only the protective efficacy of pf whole parasite vaccines for individual subjects, but also within populations of vaccinated subjects.
The United States Of America,as Represented By The Secretary, Department Of Health And Human Service


 Dispenser for dispensing a unitary dose of an active substance in a solid dosage form patent thumbnailDispenser for dispensing a unitary dose of an active substance in a solid dosage form
The invention concerns a secure device for dispensing unit doses (mi) of an active substance in a solid dosage form. Such a device comprises means to prevent refilling of the chamber containing the unit doses.
Medicodose Systems


 System and  determining a clinical trial patient burden patent thumbnailSystem and determining a clinical trial patient burden
An improved clinical trial patient burden calculating system includes a data analyzer to calculate scores and weights for patient burden components, a plurality of data calculators to calculate a respective plurality of sub patient burden indexes based on the patient burden component scores and weights, and an aggregator to calculate a procedure-level patient burden index based on aggregation of the sub patient burden indexes. An improved method for calculating clinical trial patient burden is also described and claimed..
Medidata Solutions, Inc.


 Systems and methods for matching patients with clinical trials patent thumbnailSystems and methods for matching patients with clinical trials
Systems and methods for matching of patients with clinical trials are described herein. The matching can be performed in an automated fashion and integrated with an existing clinical workflow.
University Hospitals Cleveland Medical Center


 Drug delivery device patent thumbnailDrug delivery device
Drug delivery devices are described that include sensors and processing circuitry that can detect operating events, such as flow rates and drug delivery, in various types of inhalers, such as dry powder inhalers, metered dose inhalers, nasal inhalers and nebulisers. The information determined by the processing circuitry can be used to provide feedback to the user or can be stored or transmitted for subsequent analysis.
Sagentia Limited


Cloud based emr manager


Methods are directed at utilizing a patient's electronic medical record (emr) information accessed from a cloud, such as that used in blue button technology. Once the patient's emr information is downloaded from the cloud, it is used to automatically determine if the patient is eligible to participate in a clinical trial.

Clinical trial management


Methods are directed at utilizing a cloud-based application for notifying a healthcare provider, such as a hospital or urgent care facility, that one or more patients from the healthcare provider qualify for clinical trial participation. A cloud-based application is also utilized for notifying one or more clinical trial sponsors, such as a university or pharmaceutical company, that one or more patients from one or more healthcare providers fulfill clinical trial eligibility.

Method and producing regulatory-compliant software


A system for producing a clinical trial software application includes a processor, comprising a validation service and an audit service, and a platform, configured to prove-in an infrastructure on which the software application operates. The software application operating on the infrastructure is the same as the software application previously validated in a validation portal.

System and determining site performance


An improved system for determining clinical trial site performance includes a site data filter for separating data corresponding to a clinical trial site into at least one site performance factor category data stream, where each site performance factor category comprises at least one site performance factor and each factor comprises at least one factor choice, a data stream analyzer for analyzing the site performance factor category data stream to determine a factor choice met for each site performance factor and to output a value for the determined factor choice, where the determined factor choice is multiplied by a weighting value, and an aggregator for aggregating the weighted, determined factor choices into a site performance index, where the weighting value is adjusted based on a user's input. An improved method for determining clinical trial site performance is also described and claimed..

Method and system for determining a site performance index


A method for determining a site performance index includes receiving data from one or more clinical trial sites, associating the clinical trial site data with at least one site performance factor, calculating a weighting value for the site performance factor, and generating the site performance index based on the weighted site performance factor. An apparatus for determining a site performance index is also described and claimed and includes a site data filter, a data stream analyzer, and an aggregator..

System and conducting in silico clinical trials


Described herein are computer systems and methods for generating, in silico, one or more virtual patients. The one or more virtual patients can be used, for example, to conduct a virtual clinical trial, such as to determine an efficacy of a therapy or medical device.

System and assessing subject event rate reporting


A system for assessing a clinical trial site's subject event reporting rate includes a subject event and visit count processor and a site subject event rate processor. The subject event and visit count processor receives subject event and subject visit data from a plurality of clinical trial sites and calculates for each clinical trial site a total visit count and a total subject event count.
Medidata Solutions, Inc.


System and process for patient detection, registration, follow-up and management of related documents during clinical trials


A computer system for patient detection, registration, follow-up and management of related documents during at least one clinical trial, includes at least one server having at least one clinical trials database that has at least eligibility criteria for the or each clinical trial, and an interactive interface displaying questions relating to eligibility criteria, allowing entering answers to said questions, communicating, through a communication network with the server and the clinical trials database, and displaying eligibility information. The server is programmed to determine whether a patient is eligible for a clinical trial, to generate a unique encoded identifier for each eligible patient participating in a clinical trial, to generate documents including the unique encoded identifier and data related to the clinical trial to ensure patient anonymity.

Clinical trial investigators performance assessment


A computer-implemented method for providing a user with a performance indicator score includes receiving a first transaction message that includes historical clinical-trial performance data from one or more processors at a clinical research organization and receiving a second transaction message with health records data with parameters indicative of insurance claims data. The received historical clinical-trial performance data and the prescription data is translated into an updated database.
Ims Health Incorporated


Schedule-based electronic medical record modules, applications, and uses thereof


In some aspects, the present disclosure provides a computer program product for assembling a database comprising electronic data modules, which may be electronic medical records (emrs). The present disclosure can also be used for purposes such as implementing a system in which physicians and patents can be provided with applications that they can use to confirm that various disease related events have taken place.
Revon Systems, Llc


System and determining subject conditions in mobile health clinical trials


A method for calculating a subject's state or condition comprises integrating data that are captured from multiple sources, storing the integrated data in a first database, calculating time intervals in which to collect an optimal amount of data to predict the subject state, developing a predictive model using a recorded diary or electronic data capture information, testing the model against a portion of the captured data, and applying the predictive model to new data from other sources. The predictive model may determine a subject state that may be a digital bio-marker for a disease condition.
Medidata Solutions, Inc.


System and conducting cohort trials


A computer-assisted method that includes: receiving data encoding parameters defining a study plan of a clinical trial with more than one participant clinical sites; adding a first cohort to the study plan; adding a second cohort to the study plan, the second cohort having no overlapping patient with the first cohort; subsequent to onset of the clinical trial, receiving de-identified information encoding attributes of participant human subjects at each of the clinical sites; parsing the received de-identified information to map the participant human subjects to a particular cohort of the study plan; in response to receiving update information encoding attributes of the participant human subjects at each of the clinical sites, longitudinally tracking the de-identified participant human subjects as mapped to corresponding cohorts of the study plan while the clinical trial progresses at the clinical sites; and providing analytics of the cohorts of the study plan.. .
Ims Health Incorporated


Systems and methods for managing clinical trials


Systems and methods for managing, analyzing, and evaluating clinical trials. clinical trial data collection, management, review, and analysis may be performed independent of the clinical trial.

Dynamic analysis of health and medical data applied to clinical trials


Methods, devices, systems and computer program products determine suitability of an individual for participation in a drug trial. One method for assessment of suitability of an individual for participation in a drug trial includes receiving a message that provides an identity of an individual and a request for a drug trial suitability assessment for the individual.

Contactless and minimal-contact monitoring of quality of life parameters for assessment and intervention


An apparatus, system, and method for the measurement, aggregation and analysis of data collected using non-contact or minimally-contacting sensors provides quality of life parameters for individual subjects, particularly in the context of a controlled trial of interventions on human subjects (e.g., a clinical trial of a drug, or an evaluation of a consumer item such as a fragrance). In particular, non-contact or minimal-contact measurement of quality-of-life parameters such as sleep, stress, relaxation, drowsiness, temperature and emotional state of humans may be evaluated, together with automated sampling, storage, and transmission to a remote data analysis center.
Resmed Sensor Technologies Limited


Monitoring medication adherence


A system and method of a clinical trial is provided. The system comprises a summary page providing an overview of each clinical trial participant in a graphical format, each clinical trial participant being represented by a unique clinical trial participant identifier and one or more clinical trial participant identifier modifiers applicable to modify one or more of the clinical trial participant identifiers, each modifier indicative of a different status of the particular participant identifier to which it is applied.
Ai Cure Technologies Llc


Verification of medication administration adherence


A system and method of confirming administration of medication in a clinical trial is provided. The method comprises the steps of receiving information identifying a particular medication prescription regimen in accordance with the clinical trial, determining one or more procedures for administering such prescription regimen and identifying one or more activity sequences associated with such procedures.
Ai Cure Technologies Llc


Monitoring medication adherence


A system and method of a clinical trial is provided. The system comprises a summary page providing an overview of each clinical trial participant in a graphical format, each clinical trial participant being represented by a unique clinical trial participant identifier and one or more clinical trial participant identifier modifiers applicable to modify one or more of the clinical trial participant identifiers, each modifier indicative of a different status of the particular participant identifier to which it is applied.
Ai Cure Technologies Llc


Monitoring medication adherence


A system and method of a clinical trial is provided. The system comprises a summary page providing an overview of each clinical trial participant in a graphical format, each clinical trial participant being represented by a unique clinical trial participant identifier and one or more clinical trial participant identifier modifiers applicable to modify one or more of the clinical trial participant identifiers, each modifier indicative of a different status of the particular participant identifier to which it is applied.
Ai Cure Technologies Llc


Verification of medication administration adherence


A system and method of confirming administration of medication in a clinical trial is provided. The method comprises the steps of receiving information identifying a particular medication prescription regimen in accordance with the clinical trial, determining one or more procedures for administering such prescription regimen and identifying one or more activity sequences associated with such procedures.
Ai Cure Technologies Llc


Personalized medicine service


Disclosed herein are systems, methods, and machine readable media for implementing a knowledgebase for inferring relationships between biological categories such as patient conditions, drugs, medical groups, genes, and trials, and for flexibly querying that system to access relevant categories of results, such as drugs and ongoing clinical trials. The system may be a cloud-based system..
Molecularmatch, Inc.


Treating patients with compounds or biological agents that pass the safety tests


The invention discloses a method of treatment for various severe disorders which is not treated well by current fda approved drugs. The therapeutic agents by the method are compounds or biological agents which pass safety tests in the clinical trials, but not pass the efficacy test, as safety of those compounds or biological agents are comparable with any ones in the market which pass both safety and efficacy tests in the clinical trials, combined application of those compounds or biological agents can significantly improve varied severe medical conditions..

Smart® medication adherence formulation, method, device and system for topical, vaginal or rectal routes of administration


Novel compositions, methods, systems and devices are disclosed which contain markers for definitive medication adherence monitoring for active pharmaceutical ingredients (apis) delivered topically, vaginally or rectally. This invention is useful in a wide range of contexts, including, but not limited to, clinical trial settings, home use settings, or other settings, where it is necessary to definitively confirm that a given patient has taken or been administered a given medication at the correct time and in the correct dosage via a topical, vaginal or rectal route of delivery.

Method for developing parenteral therapeutic product with drug delivery device through clinical trial


The method set out herein involves conducting clinical trial to develop parenteral therapeutic product with drug delivery device. The method comprises conducting a dose-finding clinical study using a variable dose drug delivery device to evaluate multiple clinical doses, wherein the variable dose drug delivery device is automatic, portable and for user self-administration.

System and monitoring clinical trial progress


A method for monitoring clinical trial progress includes calculating progress curves for clinical trial states. Calculating a progress curve includes assigning values to events for a datapoint in the clinical trial, generating or building pairs of values for each consecutive sequence of the events, summing up the values of pairs of events corresponding to a state change, and determining a state for the datapoint based on the sum of the values.
Medidata Solutions, Inc.


Method of discovery of effective components in herbals based on evidences by reversed-directed analysis


A method of proving safety and efficacy of herbal compounds by clinical information obtained by physicians in daily practice by implementation of network technology, chemical analysis, statistics, and clinical trials. Data for potential therapeutic compounds are directly obtained from human being in daily practice setting, application of the invention will tremendously reduce the time and costs involved in research and development of drugs..

Specimen fulfillment infrastructure


A computer system hosts a centralized data repository and a fulfillment platform. The centralized data repository receives clinical data corresponding to patients from multiple remote clinical data sources, aggregates the received clinical data, and normalizes the aggregated clinical data.
Novaseek Research Llc.


System and using decision rules to identify and abstract data from electronic health sources


The present invention has to do with a method and system for generating condition-specific registries which are essential resources for supporting epidemiological, quality improvement, and clinical trial studies. The identification of potentially eligible patients for a given registry often involves a manual process or use of ad hoc software tools.

Retrospective retrofitting method to generate a continuous glucose concentration profile by exploiting continuous glucose monitoring sensor data and blood glucose measurements


Continuous glucose monitoring (cgm) devices provide glucose concentration measurements in the subcutaneous tissue with limited accuracy and precision. Therefore, cgm readings cannot be incorporated in a straightforward manner in outcome metrics of clinical trials e.g.
UniversitÀ Degli Studi Di Padova Area Trasfermiento Di Tecnologia


Supporting execution of a clinical trial


The execution of a clinical trial is supported in the following manner. Patient model data is provided for modeling a patient-level workflow in the clinical trial in accordance with a trial protocol.
Koninklijke Philips N.v.


Plasma cell disorders


The invention relates to novel biological markers for plasma cell disorders, such as multiple myeloma, and in particular to the use of micrornas as diagnostic and prognostic markers in assays for detecting such disorders. The invention also relates to methods of determining the efficacy of treating a plasma cell disorder with a therapeutic agent, and kits for carrying 5 out the assays and methods.
Microsoft Technology Licensing, Llc


Methods and compositions for generating stable transfected cells


Methods and compositions are provided involving high producing cell lines. Embodiments concern efficient methods for screening for such cell lines and for creating such cell lines.
Maxcyte, Inc.


Enhancement of impaired motor and mental functions, using dextromethorphan and oxidase enzyme inhibitor


During clinical trials on patients suffering from neurological disorders, it has been observed that some patients obtain dramatic improvements in motor control and/or higher mental functioning, when they receive a combination of dextromethorphan and quinidine, at suitable dosages. Improved motor control has been exemplified to date by improved ability to swallow and/or speak, among victims of stroke, head injury, or als.

Enhancement of impaired motor and mental functions, using dextromethorphan and oxidase enzyme inhibitor


During clinical trials on patients suffering from neurological disorders, it has been observed that some patients obtain dramatic improvements in motor control and/or higher mental functioning, when they receive a combination of dextromethorphan and quinidine, at suitable dosages. Improved motor control has been exemplified to date by improved ability to swallow and/or speak, among victims of stroke, head injury, or als.

Methods of forecasting enrollment rate in clinical trial


In one embodiment, the present invention provides a method of designing a clinical trial enrollment plan, comprising the use of non-linear regression analysis to model the relationship between the number of investigator sites and the site enrollment rates, or the relationship between the number of investigator sites and the trial enrollment rates. One or more parameters such as the number of investigator sites, site enrollment rates, and/or trial enrollment rates can then be extrapolated from said regression analysis, wherein said extrapolated parameters are used in the design of one or more clinical trial enrollment plans.

Pharmaceutical composition for treating aids and preparation method thereof


The present invention belongs to a pharmaceutical composition preparation field of traditional chinese medicine, and more particularly relates to a pharmaceutical composition for treating aids and preparation method thereof. The pharmaceutical composition of the present invention for treating aids comprises the following raw medicinal materials: cordyceps sinensis in an amount of 3-6 parts by weight, dried radix rehmanniae in an amount of 4-12 parts by weight, mylabris in an amount of 1-3 parts by weight, and rhizoma anemarrhenae in an amount of 3-6 parts by weight.

Apparatus and collection of protocol adherence data


A data capture and storage apparatus for use in confirming administration of medication in a clinical trial or other medication administration scenario is provided. The apparatus includes a data capture device for capturing one or more types of data related to administration of a medication, a storage device for storing the captured data and a processor for processing the stored captured data.
Ai Cure Technologies Llc


Method and system for patient treatment management using interactive digital best practice treatment guidelines


A process that facilitates patient treatment management by allowing users to adhere to guidelines, best practices and medical procedures. For each individual patient the process software automatically recommends individualized treatment plans, medical tests that should be carried out, deviations or exceptions to recommended treatments and medical or clinical trials that the patient may be eligible to take part in.

Neurostimulator system, conducting a clinical trial


The invention relates to a method (200) for conducting a clinical trial with a medical device. The method (200) includes the step (202) of providing a medical device to a trial subject, the medical device being capable of providing an adjustable level of therapy.
Autonomic Technologies, Inc.


Methods and systems for interpretation and reporting of sequence-based genetic tests


Disclosed herein are system, method, and computer program product embodiments for aiding in the interpretation of variants observed in clinical sequencing data. An embodiment operates by receiving clinical trial enrollment criteria from a user, including but not limited to genetic targeting criteria; searching a knowledge base of patient test information received from a plurality of independent entities for patients that match the clinical trial enrollment criteria; and providing to the user search results for consented patients that match the clinical trial enrollment criteria..
Qiagen Gmbh


Systems and methods for clinical decision support


The present disclosure relates to systems and methods for bioinformatics and data processing. In particular, in a first aspect, the present disclosure relates to methods and systems for generating a personalized treatment guideline for a patient and for selecting a treatment for a patient.
Molecular Health Ag


Methods of subtyping crc and their association with treatment of colon cancer patients with oxaliplatin


A gene expression signature identifies stage ii colon cancer patients who will receive benefit from oxaliplatin. Oxaliplatin has been shown to lengthen the survival of colon cancer patients, when it is combined with 5-fluorouracil plus leucovorin (fulv) in nsabp clinical trial c-07.
Nsabp Foundation, Inc.


Medication adherence monitoring system and method


A medication management system is described that is operable to determine whether a user is actually following a protocol, provide additional assistance to a user, starting with instructions, video instructions, and the like, and moving up to contact from a medication administrator if it is determined that the user would need such assistance in any medical adherence situation, including clinical trial settings, home care settings, healthcare administration locations, such as nursing homes, clinics, hospitals and the like. Suspicious activity on the part of a patient or other user of the system is identified and can be noted to a healthcare provider or other service provider where appropriate..
Aic Innovations Group, Inc.


Actionability framework for genomic biomarker


An evidence-based computerized method for forming treatment plans can utilize an actionability framework, which can include a basis of actionability and a rationale for actionability for biomarkers. Treatment rules derived from data in literature, such as from clinical trials, case studies, research and published literature, can allow the method to form treatment plans with support reasoning and citations, similar to those of medical professionals.
Collabrx, Inc.


Novel high throughput assay for finding new jak3 interacting compounds, biomolecules, and inhibitors.


Janus kinase 3 is a non-receptor tyrosine kinase that mediates signals initiated by cytokines through interactions with the receptors of cytokines. Abnormal activation of jak3 was associated with human hematologic and epithelial malignancies.

Placebo formulations and uses thereof


The present technology relates to placebo compositions and their use in clinical trials for oral immunotherapy of peanut allergies. Therapy can be treatment or desensitization of peanut allergies.
Aimmune Therapeutics


Methods and kits for determining a placebo profile in subjects for clinical trials and for treatment of patients


The present invention is directed to methods and assays for identifying subjects participating in clinical trials that may exhibit a placebo response and identifying treatments for subjects with varying degrees of placebo responses. In one aspect, a method of selecting subjects to participate in a clinical trial is disclosed.
Biometheus Llc


Methods and devices for identifying improper medical reporting


Some embodiments of the invention relate to pharmaceuticals, clinical trials and reporting, and more specifically to finding duplicate medical reporting in clinical trials or when reporting adverse events attributed to drug use. Some embodiments of the invention relate to clinical trials, and more particularly to methods and devices for improving the results of clinical trials by preventing improper participation in clinical trials..

Analysis of compounds for pain and sensory disorders


The invention generally relates to optical methods for characterizing the effects of compounds on pain and other sensory phenomena. The effect of compounds on pain and other sensory phenomena may be characterized using dorsal root ganglion (drg) neurons or sensory neurons expressing optogenetic proteins that allow neural activity to be stimulated and detected optically.
Q-state Biosciences, Inc.


Compounds for use in polycystic kidney disease


Polycystic kidney disease is a cystic genetic disorder of the kidneys. Recent identification of signaling cascades de-regulated in pkd has led to the initiation of several clinical trials, but an effective therapy is still lacking.
Fondazione Telethon


System and clinical trial management


A system for managing a clinical trial includes: a server programmed for establishing a database for clinical trial management by accessing form data, defining from the form data a plurality of forms and a plurality of associated form fields, defining a clinical trial structure and database fields from the form data; and a plurality of remote programmable devices, programmed to: direct the server to access the form data, including form correlation data and form use identifiers; send to the server information about patients participating in the clinical trial, the server assigning a patient identifier to each patient; and send to the server the patient identifier for one of the patients, receive from the server, in response to the patient identifier, a subset of the forms, receive input of trial data into form fields for the subset of the plurality of forms, and send the trial data to the server.. .

Method for mimicking human clinical trial by using non-human animals


The present invention provides a method for using non-human animals to mimick human clinical trial comprising: (a) obtaining cells or tissues from n human subjects suffered from a disease, wherein n>1; (b) establishing a control group and a treatment group, wherein i) the control group comprises i control non-human animals, wherein i≧n, wherein cells or tissue from each human subject are grafted to at least one control non-human animal; ii) the treatment group comprises j treatment non-human animals, wherein j≧n, wherein cells or tissue from each human subject are grafted to at least one treatment non-human animal; and iii) each control non-human animal or treatment non-human animal is grafted with cells or tissues from one human subject; (c) administering a first agent to the control group and administering a second agent to the treatment group, wherein the first agent is different from the second agent; (d) obtaining the end point of the control group and the treatment group; and (e) comparing the end point of the control group to the end point of the treatment group.. .

Posaconazole intravenous solution formulations stabilized by substituted beta-cyclodextrin


The present invention relates to aqueous solutions useful as pharmaceutical compositions of posaconazole for intravenous administration. These compositions include a solubilizing agent, such as a modified β-cyclodextrin in an acidified solution, which can also include a chelating agent such as disodium edetate (edta).
Merck Sharp & Dohme Corp.


Clinical trial engagement tool


A clinical trial engagement tool and method execute on a mobile computing device. The tool includes displays of information containing pre-enrollment content based on searches executed on the mobile computing device, wherein access thereto is enabled without requirement of a user-specific login or security key.
Tcn Technologies, Llc


Mitochondrial toxicity test


A novel method useful in drug screening. The method is useful for testing effects of substances on the mitochondria, notably toxic or beneficial effects of drug substances or candidate drug substances.
Neurovive Pharmaceutcal Ab


Training methods for improved assaying of pain in clinical trial subjects


Provided are methods for training subjects to report pain, and for identifying accurate pain reporting subjects prior to or subsequent to training. The methods of the invention generally involve: determining the reported pain threshold and tolerance levels of the subject in response to an evoked pain stimulus; determining the reported pain of the subject in response to a natural index pain using a standard pain reporting scale; determining the response profile of the subject to noxious stimuli using a standard pain reporting scale, wherein the noxious stimuli intensity are between the pain threshold and tolerance levels of the subject; and determining the pain reporting accuracy and/or reliability of the subject..
Analgesic Solutions


Method and system for accessing patient data


Data concerning patients that have received treatment by a drug is stored and accessed to it is provided. One or more storage elements are provided that contain data concerning patients that have received the drug.
Novartis Ag




Clinical Trial topics:
  • Clinical Trial
  • Clinical Trials
  • Compliance
  • User Interface
  • Scheduling
  • Graphical User Interface
  • Stem Cells
  • Disaccharide
  • Amniotic Fluid
  • Antioxidant
  • Antioxidants
  • Bovine Serum
  • Electronic Device
  • Portable Electronic Device
  • Operational Data Store


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Clinical Trial for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Clinical Trial with additional patents listed. Browse our RSS directory or Search for other possible listings.


    0.9034

    5083

    1 - 1 - 101